|
|
Post by cm5 on Apr 30, 2016 21:24:01 GMT -5
I don't think anyone is implying that "it's not a problem for a delay for a diabetic".
In fact, everyone---patients/families/physicians/other providers/hospitals/pharmacies/those who work in healthcare management and insurance-----is constantly aggravated by the cumbersome, convoluted massive maze of process/regulation in healthcare. This is an issue every single second of every single day for everyone involved. Nothing is simple, and every box much be checked before the next step is taken. One change leads to delay until the system is updated.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Apr 30, 2016 21:48:42 GMT -5
|
|
|
|
Post by matt on May 1, 2016 8:17:56 GMT -5
It could be that the major wholesalers are not stocking product. Virtually all of the supplies in the US healthcare system are on an automatic replenishment system; the wholesalers report sales, returns, damaged goods, and other dispositions by product code by lot number by warehouse in almost real time. If the warehouse in Los Angeles is supposed to have 50,000 units on hand and the inventory drops below some trigger point, say 45,000 units, the manufacturers automatically send more product. Manufacturer driven "push" logistics work better than wholesaler driven "pull" systems for a host of reasons. If there is a recall of a certain lot, everyone knows where the product is stocked or to which customer it has been shipped. Everybody in the supply chain all the way back to the raw material suppliers and manufacturing shop floor have visibility to the inventory at an incredible level of detail, and that allows the manufacturing plant to produce in time to avoid stock outs while minimizing inventory investment.
It could just be that Sanofi, being in wind down mode, is not sending replenishment orders because they themselves are running low of Sanofi labelled product in certain regions. The wholesalers track inventory of hundreds of thousands of items by product code and to their computer system Sanofi labelled Afrezza is an entirely different product from Mannkind labelled Afrezza, and Mannkind may not have set up distribution agreements with the wholesalers yet. It doesn't help that the weekly sales are dropping since the wholesalers use the same IMS and Syphony data to determine par stocking levels, but it will all work out. In the meantime, these are the sort of bumps in the road small companies experience when they have no commercial experience. They do get sorted out eventually.
Obviously a lot of logistics are highly data driven and each member of the supply chain must have the necessary computer systems to keep up. If Mannkind was set up on the assumption that Sanofi would handle supply chain management, the company might be scrambling to install the software required to manage wholesale push orders. Again, this is just a teething issue as Mannkind transitions to full responsibility for running the business but painful just the same.
|
|
|
|
Post by kball on May 1, 2016 8:32:50 GMT -5
^
Hey Mannkind,
Hire this guy now please
|
|
|
|
Post by elv344800 on May 1, 2016 23:59:32 GMT -5
I was truly impressed with Mike's response on this querry that appeared in the blog.
He had this response on twitter almost immediately after I sent the posting to him .
Lets give the new leadership a chance now to do the job at hand. God knows they are hellbent to get this ship on an even keel again after a few short weeks of Sanofi bailing out!!!!
Hats off to you Mike C, we are appreciative here of your transparency with the on-line community.
|
|
